These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 24412678)
1. Decreased expression of CD33 in peripheral mononuclear cells of Alzheimer's disease patients. Hu N; Tan MS; Sun L; Jiang T; Wang YL; Tan L; Zhang W; Yu JT; Tan L Neurosci Lett; 2014 Mar; 563():51-4. PubMed ID: 24412678 [TBL] [Abstract][Full Text] [Related]
2. Increased expressions of TLR2 and TLR4 on peripheral blood mononuclear cells from patients with Alzheimer's disease. Zhang W; Wang LZ; Yu JT; Chi ZF; Tan L J Neurol Sci; 2012 Apr; 315(1-2):67-71. PubMed ID: 22166855 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of TREM2 in peripheral blood of Alzheimer's disease patients. Hu N; Tan MS; Yu JT; Sun L; Tan L; Wang YL; Jiang T; Tan L J Alzheimers Dis; 2014; 38(3):497-501. PubMed ID: 24002183 [TBL] [Abstract][Full Text] [Related]
4. Increased alpha 7 nicotinic acetylcholine receptor protein levels in Alzheimer's disease patients. Chu LW; Ma ES; Lam KK; Chan MF; Lee DH Dement Geriatr Cogn Disord; 2005; 19(2-3):106-12. PubMed ID: 15591800 [TBL] [Abstract][Full Text] [Related]
5. Circulating miR-125b as a biomarker of Alzheimer's disease. Tan L; Yu JT; Liu QY; Tan MS; Zhang W; Hu N; Wang YL; Sun L; Jiang T; Tan L J Neurol Sci; 2014 Jan; 336(1-2):52-6. PubMed ID: 24139697 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of late-onset Alzheimer disease genetic susceptibility risks in a Canadian population. Omoumi A; Fok A; Greenwood T; Sadovnick AD; Feldman HH; Hsiung GY Neurobiol Aging; 2014 Apr; 35(4):936.e5-12. PubMed ID: 24176626 [TBL] [Abstract][Full Text] [Related]
7. Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex. Walker DG; Whetzel AM; Serrano G; Sue LI; Beach TG; Lue LF Neurobiol Aging; 2015 Feb; 36(2):571-82. PubMed ID: 25448602 [TBL] [Abstract][Full Text] [Related]
8. Systemic immune responses in Alzheimer's disease: in vitro mononuclear cell activation and cytokine production. Pellicanò M; Bulati M; Buffa S; Barbagallo M; Di Prima A; Misiano G; Picone P; Di Carlo M; Nuzzo D; Candore G; Vasto S; Lio D; Caruso C; Colonna-Romano G J Alzheimers Dis; 2010; 21(1):181-92. PubMed ID: 20413861 [TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of peripheral blood leukocytes shows consistent longitudinal downregulation of TOMM40 and upregulation of KIR2DL5A, PLOD1, and SLC2A8 among fast progressors in early Alzheimer's disease. Chong MS; Goh LK; Lim WS; Chan M; Tay L; Chen G; Feng L; Ng TP; Tan CH; Lee TS J Alzheimers Dis; 2013; 34(2):399-405. PubMed ID: 23234877 [TBL] [Abstract][Full Text] [Related]
10. Exploring the value of plasma BIN1 as a potential biomarker for alzheimer's disease. Sun L; Tan MS; Hu N; Yu JT; Tan L J Alzheimers Dis; 2013; 37(2):291-5. PubMed ID: 23803295 [TBL] [Abstract][Full Text] [Related]
11. Increased glutaminyl cyclase expression in peripheral blood of Alzheimer's disease patients. Valenti MT; Bolognin S; Zanatta C; Donatelli L; Innamorati G; Pampanin M; Zanusso G; Zatta P; Dalle Carbonare L J Alzheimers Dis; 2013; 34(1):263-71. PubMed ID: 23207485 [TBL] [Abstract][Full Text] [Related]
12. The effect of CD33 expression on inflammatory response in chronic obstructive pulmonary disease. Zhang LX; Ye J; Chen YB; Peng HL; Chen X; Liu L; Jiang AG; Huang JX Immunol Invest; 2013; 42(8):701-10. PubMed ID: 23845152 [TBL] [Abstract][Full Text] [Related]
13. Peripheral level of CD33 and Alzheimer's disease: a bidirectional two-sample Mendelian randomization study. Gu X; Dou M; Cao B; Jiang Z; Chen Y Transl Psychiatry; 2022 Oct; 12(1):427. PubMed ID: 36192375 [TBL] [Abstract][Full Text] [Related]
14. CD33 rs2455069 SNP: Correlation with Alzheimer's Disease and Hypothesis of Functional Role. Tortora F; Rendina A; Angiolillo A; Di Costanzo A; Aniello F; Donizetti A; Febbraio F; Vitale E Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408990 [TBL] [Abstract][Full Text] [Related]
19. CD33 mRNA Has Elevated Expression Levels in the Leukocytes of Peripheral Blood in Patients with Late-Onset Alzheimer's Disease. Heidari F; Ansstas G; Ajamian F Gerontology; 2022; 68(4):421-430. PubMed ID: 34569532 [TBL] [Abstract][Full Text] [Related]
20. The evaluation of neutrophil-lymphocyte ratio in Alzheimer's disease. Kuyumcu ME; Yesil Y; Oztürk ZA; Kizilarslanoğlu C; Etgül S; Halil M; Ulger Z; Cankurtaran M; Arıoğul S Dement Geriatr Cogn Disord; 2012; 34(2):69-74. PubMed ID: 22922667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]